This study investigates pancreatic cancer with peritoneal involvement. The purpose of this study is to assess the feasibility and safety of combining surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
The study evaluates the safety and feasibility of this combined treatment approach. It looks at how this treatment affects patients' safety and their quality of life after the procedure.
- Who can participate: Adults over 18 years with pancreatic adenocarcinoma and confirmed peritoneal metastasis can participate. Participants must have good performance status and provide informed consent.
- Study details: Participants will undergo surgery to remove the pancreatic tumor and visible metastases, followed by HIPEC treatment. A placebo is not used in this study.